Kiniksa Pharmaceuticals Ltd(KNSA) is a stock of interest due to its movements. Here at Wall Street Facts we only cover the best stocks so make sure you check out our other articles. Today we will be diving deep into all of the essential information you need to know about KNSA. We will be studying the movemnt so you can make the best descision as an investor.
First, we should get to know the company in discussion today. Here is a little about them: Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, Vixarelimab, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Hamilton, Bermuda.
The stock has moved upwards today by 1%. The high for today is 18.74 and today’s low is 18.02. This information is critical in deciding whether this investment is risky or safe. We can see the stock is trending upwards, which means the volume of people selling this stock is greater than people buying it. Next we will be going over the forecast.
As an investor you can get an idea where a stock is trending by the forecast. In this case the high forecast for Kiniksa Pharmaceuticals Ltd is 39.00 and the low forecast is 34.00. We can also get a look into the future by looking at past trends. Looking at Kiniksa Pharmaceuticals Ltd’s 5 year movement it seems it has fallen 6%.
If you found this article helpful please check out our others or signup for our newsletter below!